|
A.V. Dubinina, A.I. Kochetkov, A.E. Vorobyova, S.S. Eremina, K.B. Mirzaev, O.D. Ostroumova
Analysis of the structure of comorbidities and pharmacotherapy in patients with a combination of atrial fibrillation and coronary heart disease
|
№14 / 2023
|
|
O.D. Ostroumova, A.V. Dubinina, V.A. De, A.I. Kochetkov, V.B. Dashabylova, S.S. Eremina, M.V. Klepikova
On the issue of improving the safety of antithrombotic therapy in patients with atrial fibrillation and coronary heart disease receiving antithrombotic therapy
|
№14 / 2023
|
|
V.S. Nikiforov
Possibilities of using trimetazidine in comorbid cardiovascular pathology and metabolic disorders
|
№13 / 2022
|
|
B.G. Iskenderov, A.V. Zaitseva, I.N. Mozhzhukhin, M.G. Ivanchukova
Impact of coronary artery stenting on the course of chronic kidney disease in patients with stable angina
|
№13 / 2022
|
|
O.A. Polyakova (1), A.A. Chochua (1), O.V. Golovina (1), E.V. Mironova (2), O.D. Ostroumova (1)
Possibilities of using trimetazidine in the treatment of patients with ischemic heart disease and chronic heart failure
|
№13 / 2021
|
|
O.D. Ostroumova (1, 2), A.I. Kochetkov (1), S.V. Batyukina (1), N.L. Lyakhova (3)
Approaches to choosing a direct oral anticoagulant in the treatment of polymorbid patients with atrial fibrillation
|
№3 / 2020
|
|
N.P. Lyamina (1), A.V. Kosareva (2)
The justified position of rosuvastatin in therapeutic practice
|
№9 / 2019
|
|
M.V. Ezhov
EVOLOUCUMAB - NEW HYPOLIDEPHEMIC AGENT FOR CARDIOVASCULAR RISK REDUCTION
|
№20 / 2017
|
|
E.A. Kolomiets, N.S. Besova, I.A. Kurmukov, Sh.R. Kashia, M.N. Narimanov, A.P. Sandomirskaya
CARDIOVASCULAR TOXICITY OF FLUOROPIRYMIDINES
|
№18 / 2017
|
|
M.V. Ezhov, E.V. Sorokin
SAFETY AND EFFICACY OF LONG-TERM THERAPY WITH HIGH DOSES OF ATORVASTATIN
|
№15 / 2017
|
|
M.E. Statsenko, S.V. Turkina, I.A. Tyshchenko, S.V. Fabritskaya, L.V. Poletaeva
POTENTIALS FOR THE DRUG CORRECTION OF SECONDARY MITOCHONDRIAL DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND COMORBID PATHOLOGY
|
№6 / 2017
|
|
A.F. Verbovoy, L.A. Sharonova
DIABETES MELLITUS AND CORONARY ARTERY DISEASE: FEATURES OF CLINICAL MANIFESTATION AND TREATMENT.
|
№16 / 2016
|
Русский
